CA 19-9 in pancreatic cancer screening

2018-04-25
Paul Moayyedi

What is the role of cancer antigen (CA) 19-9 in screening for pancreatic cancer?

Paul Moayyedi: Because pancreatic cancer mercifully is still very rare in the general population, the positive predictive value [of CA 19-9] is actually very poor. It is not a useful screening test at this stage.

Of course, as you alluded to in the last question [see Screening tests for pancreatic cancer], if we can find a biomarker that is more sensitive and specific, then perhaps that will change in the future. As of now, we would not recommend screening the general population.

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.